MedInvent, a company based in Medina, Ohio, received European CE Mark approval for its NasoNeb II Nasal Nebulizer. The device is intended for patients with chronic sinusitis and allergic rhinitis, delivering drugs (typically budesonide) into the nasal and paranasal sinus cavities.
The company says the product provides superior spread of the drug through the target sinuses and promises “no pulmonary deposition.”
It can be used by patients at home, each session lasting only a couple minutes. Components are made to be easily washed and reused.
Here’s a company promo video introducing the NasoNeb system:
Product page: NasoNeb Nasal Nebulizer…
Via: MedInvent…